Cfo4 Life Group, LLC Pfizer Inc Transaction History

Cfo4 Life Group, LLC

$562 Million
Q1 2025

A detailed history of Cfo4 Life Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cfo4 Life Group, LLC holds 25,334 shares of PFE stock, worth $591,548. This represents 0.11% of its overall portfolio holdings.

Number of Shares

25,334

Previous 28,725 11.81%

Holding current value

$591,548

Previous $762,000 15.88%

% of portfolio

0.11%

Previous 0.14%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	SELL	$25.01 - $27.13 $84,808 - $91,997	-3,391 Reduced 11.81%	25,334 $641,000
Q4 2024 Feb 10, 2025	BUY	$24.8 - $30.19 $15,227 - $18,536	614 Added 2.18%	28,725 $762,000
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $23,905 - $27,089	863 Added 3.17%	28,111 $813,000
Q2 2024 Jul 31, 2024	BUY	$25.26 - $29.6 $39,026 - $45,732	1,545 Added 6.01%	27,248 $762,000
Q1 2024 May 06, 2024	BUY	$25.89 - $29.73 $25,501 - $29,284	985 Added 3.98%	25,703 $713,000
Q4 2023 Jan 24, 2024	SELL	$26.13 - $33.94 $28,168 - $36,587	-1,078 Reduced 4.18%	24,718 $711,000
Q3 2023 Oct 30, 2023	SELL	$32.09 - $37.51 $78,684 - $91,974	-2,452 Reduced 8.68%	25,796 $855,000
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $10,836 - $12,537	-300 Reduced 1.05%	28,248 $1.04 Million
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $7,878 - $10,256	-200 Reduced 0.7%	28,548 $1.16 Million
Q4 2022 Feb 03, 2023	BUY	$41.75 - $54.5 $54,066 - $70,577	1,295 Added 4.72%	28,748 $1.47 Million
Q3 2022 Oct 19, 2022	SELL	$43.76 - $53.42 $73,079 - $89,211	-1,670 Reduced 5.73%	27,453 $1.2 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $132,796 - $157,455	-2,854 Reduced 8.93%	29,123 $1.48 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $30,012 - $37,188	-656 Reduced 2.01%	31,977 $1.66 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $63,054 - $93,467	-1,526 Reduced 4.47%	32,633 $1.93 Million
Q3 2021 Oct 12, 2021	BUY	$39.25 - $50.42 $116,101 - $149,142	2,958 Added 9.48%	34,159 $1.47 Million
Q2 2021 Jul 14, 2021	SELL	$35.91 - $40.68 $79,971 - $90,594	-2,227 Reduced 6.66%	31,201 $1.22 Million
Q1 2021 Apr 20, 2021	SELL	$33.49 - $37.77 $124,147 - $140,013	-3,707 Reduced 9.98%	33,428 $1.21 Million
Q4 2020 Jan 12, 2021	BUY	$33.47 - $42.56 $132,742 - $168,792	3,966 Added 11.96%	37,135 $1.37 Million
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $9,175 - $10,765	289 Added 0.88%	33,169 $1.22 Million
Q2 2020 Jul 15, 2020	SELL	$30.12 - $36.54 $21,445 - $26,016	-712 Reduced 2.12%	32,880 $1.08 Million
Q1 2020 Apr 16, 2020	SELL	$27.03 - $38.62 $68,710 - $98,172	-2,542 Reduced 7.03%	33,592 $1.1 Million
Q4 2019 Jan 22, 2020	SELL	$32.92 - $37.36 $73,839 - $83,798	-2,243 Reduced 5.84%	36,134 $1.42 Million
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $567,015 - $735,252	-17,452 Reduced 31.26%	38,377 $1.38 Million
Q2 2019 Jul 29, 2019	BUY	$36.98 - $41.52 $71,149 - $79,884	1,924 Added 3.57%	55,829 $2.42 Million
Q1 2019 Apr 22, 2019	SELL	$37.5 - $41.2 $257,700 - $283,126	-6,872 Reduced 11.31%	53,905 $2.29 Million
Q4 2018 Feb 01, 2019	SELL	$38.47 - $43.86 $99,906 - $113,904	-2,597 Reduced 4.1%	60,777 $2.65 Million
Q3 2018 Oct 25, 2018	SELL	$34.47 - $41.81 $930 - $1,128	-27 Reduced 0.04%	63,374 $2.79 Million
Q2 2018 Aug 01, 2018	BUY	$32.98 - $35.16 $1.89 Million - $2.01 Million	57,282 Added 936.13%	63,401 $2.3 Million
Q1 2018 May 07, 2018	SELL	$31.91 - $37.02 $3,031 - $3,516	-95 Reduced 1.53%	6,119 $217,000
Q4 2017 Jan 22, 2018	BUY	$33.26 - $35.29 $6,286 - $6,669	189 Added 3.14%	6,214 $225,000
Q3 2017 Nov 09, 2017	SELL	$31.0 - $34.15 $14,012 - $15,435	-452 Reduced 6.98%	6,025 $215,000
Q2 2017 Aug 08, 2017	BUY	N/A	6,477	6,477 $218,000

Others Institutions Holding PFE

# of Institutions

3,368

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $131B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfo4 Life Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfo4 Life Group, LLC with notifications on news.

Account

Cfo4 Life Group, LLC Pfizer Inc Transaction History